Next Generation Sequencing Of The BCR ABL1 Kinase Domain May Be Beneficial In Decision Making Among Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor Resistance


ERBİLGİN Y., Eşkazan E., HATIRNAZ NG Ö. , Salihoğlu A., ELVERDİ T., Fırtına S., et al.

55.th ASH meeting, 7 - 10 Aralık 2013, cilt.122

  • Cilt numarası: 122